Re thabetse ho ikopanya le baetapele ba indasteri ho CPHI South East Asia 2025, ho tloha ka Phupu 16 ho isa la 18 ho MITEC Kuala Lumpur. Ketsahalo ena e feta lisekoere-mithara tse 15,000 'me e tla ba le bahoeletsi ba ka bang 400. Ho lebelletsoe hore litsebi tse fetang 8,000 li tla ba teng, hammoho le li-seminar le liforamu tse fetang 60 tse shebaneng le mekhoa ea hajoale ea indasteri, mahlale a macha le nts'etsopele ea taolo. Ke monyetla o babatsehang oa ho etsa marang-rang le tšebelisano-'moho ho pholletsa le ketane ea phepelo ea meriana.

Mabapi le JYMed
 
JYMed ke k'hamphani e etelletseng pele ea litlhare tse shebaneng le peptide e sebetsanang le lipatlisiso, nts'etsopele, tlhahiso le khoebo. Re fana ka lits'ebeletso tse kopantsoeng ka botlalo tsa CDMO tse etselitsoeng bareki ba meriana, ba litlolo le ba bongaka ba liphoofolo lefatšeng ka bophara.

Potefolio ea rona e kenyelletsa mefuta e mengata e fapaneng ea li-API tsa peptide. Lihlahisoa tsa li-Flagship tse kang Semaglutide le Tirzepatide li atlehile ho tlatsa US FDA DMF filings.

Tlas'a rona, Hubei JXBio, e tsamaisa mela e tsoetseng pele ea tlhahiso ea peptide API e hahiloeng ho fihlela litekanyetso tsa cGMP ho tsoa ho US FDA le NMPA ea China. Setsi sena se kenyelletsa mekhoa e 10 e meholo ea tlhahiso le ea lifofane 'me e tšehetsoa ke mekhoa e matla ea Tsamaiso ea Boleng (QMS) le ea Environmental Health and Safety (EHS).

JXBio e fetile tlhahlobo ea GMP ho tsoa ho US FDA le NMPA ea China. Re motlotlo ho elelloa ke balekane ba lefats'e ba etsang meriana bakeng sa bokhabane ba boleng, polokeho, le tumellano ea tikoloho.

LIHLAHISO TSE KHOLO

Iteanye le rona
Bakeng sa lipotso, ikutloe u lokolohile ho ikopanya le bona:
● Lipotso tsa Global API & Cosmetic:+ 86-150-1352-9272
● Ngoliso ea API & Litšebeletso tsa CDMO (US & EU):+ 86-158-1868-2250
● Imeile: jymed@jymedtech.com
● Aterese:Mokatong oa 8 & 9, Mohaho oa 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Seterekeana sa Kengzi, Setereke sa Pingshan, Shenzhen, Chaena.